The industry and FDA effort to reauthorize PDUFA likely will be linked to and influenced by the 21st Century Cures bill, like it or not.
Industry in particular will have to deal with the potential overlap and influence that the Cures legislation could wield, especially since both bills may
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?